Literature DB >> 20308022

Sensitive quantification of sirolimus and everolimus by LC-MS/MS with online sample cleanup.

Daniel M Mueller1, Katharina M Rentsch.   

Abstract

Sirolimus and its derivative everolimus are widely used today as immunosuppressive agents for example in the transplantation medicine. The problematic pharmacokinetic behavior of those substances makes therapeutic drug monitoring mandatory. Therefore, a fast, simple and sensitive high-throughput procedure using online extraction with turbulent flow chromatography for the concurrent measurement of sirolimus and everolimus has been developed. 200 microl of whole blood was mixed with internal standard (23-desmethoxyrapamycin) and the precipitation solution and centrifuged. An aliquot of the supernatant was transferred into autosampler vials. 50 microl of the supernatant was injected into the LC system, where the analytes were extracted using turbulent flow chromatography and thereafter analyzed using reversed phase chromatography. Detection was done by atmospherical pressure chemical ionization (APCI) mass spectrometry in the negative ionization mode. The method has been fully validated and compared to a previously used method. The method was shown to be linear over the entire calibration range (2.2-43.7 microg/l for everolimus and 2.9-51.2 microg/l for sirolimus). The lower limit of quantification was 0.5 microg/l for both compounds. For within-day and between-day analysis, the CV's were <7.6% for everolimus and <8.7% for sirolimus, respectively. The accuracy was between 92.1% and 105% for everolimus and 96.1% and 106% for sirolimus. Recovery ranged between 46.3% and 50.6% for everolimus and 51.2% and 57.2% for sirolimus. The method was demonstrated to be free of matrix effects and comparable to the previously used method. The presented LC-MS/MS method, using turbulent flow chromatography online extraction, allows a fast, simple and reliable determination of everolimus and sirolimus. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20308022     DOI: 10.1016/j.jchromb.2010.02.029

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  In vivo solid-phase microextraction for monitoring intravenous concentrations of drugs and metabolites.

Authors:  Heather L Lord; Xu Zhang; F Marcel Musteata; Dajana Vuckovic; Janusz Pawliszyn
Journal:  Nat Protoc       Date:  2011-06-02       Impact factor: 13.491

2.  Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice.

Authors:  Sefika Ozcelik; Graham Fraser; Perrine Castets; Véronique Schaeffer; Zhiva Skachokova; Karin Breu; Florence Clavaguera; Michael Sinnreich; Ludwig Kappos; Michel Goedert; Markus Tolnay; David Theo Winkler
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.